Company Update

Pure Malaysia obtains its MDA Establishment licence

Malaysia, a key gateway to Southeast Asia, offers strategic access for businesses. Understanding medical device regulations is crucial for market entry.

Published on:
April 22, 2024

Malaysia is centrally located within Southeast Asia, and is an ideal regional gateway for overseas companies to venture into Southeast Asia. In the north, Perlis, Kedah, Perak and Kelantan share a border with Thailand and people on either side speak both Thai and Malay. In Sabah, the Malay diaspora extends to the southern part of the Philippines which has aporous border. Malaysia also shares a land border with Indonesia and Brunei in the island of Borneo. In the South, its border with Singapore allows thousands of people to commute each day for work and trade.

The Malaysian medical device market is an important one, given its significant size and potential for growth. However, before medical devices can be marketed and sold in Malaysia, they must be registered with the Malaysian Medical Device Authority (MDA) and comply with the country's regulatory requirements, to ensure that products are safe, effective, and of high quality.

For companies to register and hold MDA medical device certs, they must first obtain what is known as an “Establishment licence”, of which the detailed requirements are specified under Section 15 of the Medical Device Act 2012 (Act 737). All establishments as defined in Section 2 of the Act 737 shall obtain a license/licenses before they can import, export or place a medical device in the market.

Pure Malaysia is now able to act as your Authorized Representative (AR) in Malaysia. By having a neutral third party such as Pure Global hold your MDA medical device licence, you can easily switch distributors immediately without the hassle of re-registering your product with MDA which may take 6 months or more.

Contact us for a non-obligatory discussion today!

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Read more

Latest News

Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.

Regulatory Update
December 18, 2024

Closing out 2024, we bring you substantial medical device updates from Europe, Brazil, and beyond, including the launch of public consultation on EU device regulations, an updated roadmap for regulatory implementations in the UK, and several new and updated resolutions in Brazil.

Regulatory Update
December 11, 2024

Early December 2024 regulatory news brings updates from Europe, US, Brazil, China, and Japan, including new FDA guidance on change controls for AI-enabled devices and an innovation-focused approach to clinical research regulations in Brazil.

An extensive round-up of medical device regulatory news from November 2024 includes new and updated guidance documents, Q&As, and directives from Europe and the US, including the new EU Product Liability Directive for AI and Smart Products.

Pure Global is proud to announce its inclusion in the China Business Service Providers (BSP) directory on the International Trade Administration website.

Contact us
Request information

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Our closest representative will get back to you within 24 hours.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Latest Blog Content

Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.

Pure Global 2024 Year in Review
Blog Article
Pure Global 2024 Year in Review

As 2024 comes to a close, Pure Global proudly reflects on a transformative year marked by substantial growth, cutting-edge innovation, and impactful collaborations.

Risk increases compliance chalenges under IVDR
Blog Article
What are the challenges under IVDR?

IVD manufacturers cite the new classification system, detailed definitions for intended purposes, and the need for verification of clinical evidence as key challenges under the IVDR.

Blog Article
EU Parliament Revises MDR and IVDR

On October 23, the European Parliament adopted a resolution revising specific elements of the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Devices Regulation (IVDR). This resolution intends to address ongoing challenges in implementing the regulations by 2025 and to improve patient access to important medical products.

Blog Article
Language Challenges in MedTech Going Global and Our Solution

Multilingual documentation presents ongoing compliance and logistical hurdles for MedTech manufacturers. Transla.Ai is an industry-specific translation tool that can accelerate and streamline the translation process.